Short to medium term outcomes of right ventricular outflow tract stenting as initial palliation for symptomatic infants with complete atrioventricular septal defect with associated tetralogy of Fallot
- PMID: 33022100
- DOI: 10.1002/ccd.29306
Short to medium term outcomes of right ventricular outflow tract stenting as initial palliation for symptomatic infants with complete atrioventricular septal defect with associated tetralogy of Fallot
Abstract
Objectives: To assess the impact of right ventricular outflow tract (RVOT) stenting as the primary palliation in infants with complete atrioventricular septal defect with associated tetralogy of Fallot (cAVSD/TOF).
Background: Historically, palliation of symptomatic patients with cAVSD/TOF has been achieved through surgical systemic to pulmonary artery shunting. More recently RVOT stenting has evolved as an acceptable alternative in patients with tetralogy of Fallot.
Methods: Retrospective review of all patients with cAVSD/TOF who underwent RVOT stenting as palliation over a 13-year period from two large tertiary referral centers.
Results: Twenty-six patients underwent RVOT stenting at a median age of 57 days (interquartile range [IQR] 25.5-106.5). Median weight for stent deployment was 3.7 kg (IQR 2.91-5.5 kg). RVOT stenting improved oxygen saturations from a median of 72% (IQR 70-76%) to 90% (IQR 84-92%), p < .001. There was a significant increase in the median Z-score for both branch pulmonary arteries at median follow-up of 255 days (IQR 60-455). Eight patients required RVOT stent balloon dilatations and 8 patients required re-stenting for progressive desaturation. The median duration between reinterventions was 122 days (IQR 53-294 days). Four patients died during the follow-up period. No deaths resulted from the initial intervention. To date, definitive surgical intervention was achieved in 19 patients (biventricular repair n = 15) at a median age of 369 days (IQR 223-546 days).
Conclusion: RVOT stenting in cAVSD/TOF is a safe and effective palliative procedure in symptomatic infants, promoting pulmonary artery growth and improving oxygen saturations.
Keywords: Trisomy 21; congenital heart defects; palliation.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Najm HK, Van Arsdell GS, Watzka S, Hornberger L, Coles JG, Williams WG. Primary repair is superior to initial palliation in children with atrioventricular septal defect and tetralogy of fallot. J Thorac Cardiovasc Surg. 1998;116(6):905-913.
-
- Uretzky G, Puga FJ, Danielson GK, et al. Complete atrioventricular canal associated with tetralogy of Fallot. Morphologic and surgical considerations. J Thorac Cardiovasc Surg. 1984;87(5):756-766.
-
- McElhinney DB, Mohan Reddy V, Silverman NH, Brook MM, Hanley FL. Atrioventricular septal defect with common valvar orifice and tetralogy of Fallot revisited: making a case for primary repair in infancy. Cardiol Young. 1998;8(4):455-461.
-
- Pacifico AD, Kirklin JW, Bargeron LM. Repair of complete atrioventricular canal associated with tetralogy of Fallot or double-outlet right ventricle: report of 10 patients. Ann Thorac Surg. 1980;29(4):351-356.
-
- Brancaccio BG, Michielon G, Filippelli S, et al. Transannular patching is a valid alternative for tetralogy of Fallot and complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg. 2009;137(4):919-923.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
